Literature DB >> 27246656

Recent advances in the production of recombinant subunit vaccines in Pichia pastoris.

Man Wang1, Shuai Jiang2, Yefu Wang2.   

Abstract

Recombinant protein subunit vaccines are formulated using defined protein antigens that can be produced in heterologous expression systems. The methylotrophic yeast Pichia pastoris has become an important host system for the production of recombinant subunit vaccines. Although many basic elements of P. pastoris expression system are now well developed, there is still room for further optimization of protein production. Codon bias, gene dosage, endoplasmic reticulum protein folding and culture condition are important considerations for improved production of recombinant vaccine antigens. Here we comment on current advances in the application of P. pastoris for the synthesis of recombinant subunit vaccines.

Entities:  

Keywords:  Pichia pastoris; immunogenicity; protective efficacy; recombinant expression; subunit vaccine

Mesh:

Substances:

Year:  2016        PMID: 27246656      PMCID: PMC4927204          DOI: 10.1080/21655979.2016.1191707

Source DB:  PubMed          Journal:  Bioengineered        ISSN: 2165-5979            Impact factor:   3.269


  96 in total

1.  Enhancing functional production of G protein-coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen.

Authors:  Nicolas André; Nadia Cherouati; Cécile Prual; Tania Steffan; Gabrielle Zeder-Lutz; Thierry Magnin; Franc Pattus; Hartmut Michel; Renaud Wagner; Christoph Reinhart
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

Review 2.  Heterologous protein expression in the methylotrophic yeast Pichia pastoris.

Authors:  J L Cereghino; J M Cregg
Journal:  FEMS Microbiol Rev       Date:  2000-01       Impact factor: 16.408

Review 3.  Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines.

Authors:  S Liljeqvist; S Ståhl
Journal:  J Biotechnol       Date:  1999-07-30       Impact factor: 3.307

Review 4.  Heterologous protein production using the Pichia pastoris expression system.

Authors:  Sue Macauley-Patrick; Mariana L Fazenda; Brian McNeil; Linda M Harvey
Journal:  Yeast       Date:  2005-03       Impact factor: 3.239

5.  Molecular characterization of the 3-phosphoglycerate kinase gene (PGK1) from the methylotrophic yeast Pichia pastoris.

Authors:  João Ricardo Moreira de Almeida; Lídia Maria Pepe de Moraes; Fernando Araripe Gonçalves Torres
Journal:  Yeast       Date:  2005-07-15       Impact factor: 3.239

6.  Determinants of autoantibody induction by conjugated papillomavirus virus-like particles.

Authors:  Bryce Chackerian; Petra Lenz; Douglas R Lowy; John T Schiller
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

Review 7.  Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

Authors:  Gillian M Keating; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Expression of a Rhizopus oryzae lipase in Pichia pastoris under control of the nitrogen source-regulated formaldehyde dehydrogenase promoter.

Authors:  David Resina; Alícia Serrano; Francisco Valero; Pau Ferrer
Journal:  J Biotechnol       Date:  2004-04-08       Impact factor: 3.307

9.  Operational strategies, monitoring and control of heterologous protein production in the methylotrophic yeast Pichia pastoris under different promoters: a review.

Authors:  Oriol Cos; Ramón Ramón; José Luis Montesinos; Francisco Valero
Journal:  Microb Cell Fact       Date:  2006-04-06       Impact factor: 5.328

10.  Vaccines: past, present and future.

Authors:  Stanley A Plotkin
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

View more
  19 in total

1.  Recombinant Opisthorchis viverrini tetraspanin expressed in Pichia pastoris as a potential vaccine candidate for opisthorchiasis.

Authors:  Luyen Thi Phung; Sujittra Chaiyadet; Nuttanan Hongsrichan; Javier Sotillo; Hang Dinh Thi Dieu; Canh Quang Tran; Paul J Brindley; Alex Loukas; Thewarach Laha
Journal:  Parasitol Res       Date:  2019-11-14       Impact factor: 2.289

2.  Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System.

Authors:  Jyoti Gupta; Amit Kumar; Milan Surjit
Journal:  Methods Mol Biol       Date:  2022

3.  Overcoming Obstacles in Protein Expression in the Yeast Pichia pastoris: Interviews of Leaders in the Pichia Field.

Authors:  Zoe Ingram; Abha Patkar; Dahoon Oh; Kevin K Zhang; Christina Chung; Joan Lin-Cereghino; Geoff P Lin-Cereghino
Journal:  Pac J Health (Stockt)       Date:  2021

4.  Recombinant expression of hen egg white lysozyme with the assistance of xylanase fusion partner in Pichia pastoris.

Authors:  Lin Cui; Huoqing Huang; Honglian Zhang; Xiaolu Wang; Xing Qin; Tao Tu; Jie Zhang; Xiaoyun Su; Huimin Yu; Yingguo Bai; Huiying Luo; Bin Yao; Yuan Wang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 5.  Mucosal Vaccination: A Promising Alternative Against Flaviviruses.

Authors:  Rosendo Luria-Pérez; Luis A Sánchez-Vargas; Paola Muñoz-López; Gabriela Mellado-Sánchez
Journal:  Front Cell Infect Microbiol       Date:  2022-06-15       Impact factor: 6.073

6.  Cultivation of Pichia pastoris carrying the scFv anti LDL (-) antibody fragment. Effect of preculture carbon source.

Authors:  Cesar Andres Diaz Arias; Daniela de Araujo Viana Marques; Luciana Pellegrini Malpiedi; Andrea Queiroz Maranhão; Dulcineia Abdalla Saes Parra; Attilio Converti; Adalberto Pessoa Junior
Journal:  Braz J Microbiol       Date:  2017-02-09       Impact factor: 2.476

Review 7.  Pichia pastoris: A highly successful expression system for optimal synthesis of heterologous proteins.

Authors:  Mohsen Karbalaei; Seyed A Rezaee; Hadi Farsiani
Journal:  J Cell Physiol       Date:  2020-02-14       Impact factor: 6.384

8.  Protective Malaria Vaccine in Mice Based on the Plasmodium vivax Circumsporozoite Protein Fused with the Mumps Nucleocapsid Protein.

Authors:  Rodolfo F Marques; Alba Marina Gimenez; Eduardo Aliprandini; Janaina T Novais; Diego P Cury; Ii-Sei Watanabe; Mariana R Dominguez; Eduardo L V Silveira; Rogerio Amino; Irene S Soares
Journal:  Vaccines (Basel)       Date:  2020-04-19

Review 9.  Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?

Authors:  Wei Zhan; Manish Muhuri; Phillip W L Tai; Guangping Gao
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

Review 10.  The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.

Authors:  Sonali Kochhar; Denny Kim; Jean-Louis Excler; Richard C Condit; James S Robertson; Stephen Drew; Mike Whelan; David Wood; Patricia E Fast; Marc Gurwith; Bettina Klug; Najwa Khuri-Bulos; Emily R Smith; Robert T Chen
Journal:  Vaccine       Date:  2020-07-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.